Comparable clinical, endoscopic and histologic efficacy and tolerability of standard doses of ranitidine, omeprazole and pantoprazole in patient with gastro-esophageal reflux disease (GORD) (CROSBI ID 504806)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Pulanić, Roland ; Premužić, Marina ; Brkić, Tomislav ; Opačić, Milorad ; Zorić, Vladimir, Curiš, Nada ; Jokić-Begić, Nataša
engleski
Comparable clinical, endoscopic and histologic efficacy and tolerability of standard doses of ranitidine, omeprazole and pantoprazole in patient with gastro-esophageal reflux disease (GORD)
The aim of this double-blind, controlled and randomised study was to compare efficacy and tolerability of standard doses of ranitidine, omeprazole and pantoprazole. We concluded that pantoprazole is highly effective and well tolerated in the treatment of GORD.
Reflux oesophagitis; Therapy; PPI
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
A126-x.
2003.
objavljeno
Podaci o matičnoj publikaciji
11th UEGW, poster presentations, GUT
Spiller, Robin
London : Delhi: British Society of gastroenterology
Podaci o skupu
11th United European Gastroenterology Week
poster
01.11.2003-05.11.2003
Madrid, Španjolska
